Searched for *.

1. There is no excuse for the world to still have malaria (Page)

   There is no excuse for the world to still have malaria

   Relevance:
   https://www.swisstph.ch/en/impact-stories/there-is-no-excuse-for-the-world-to-still-have-malaria

   In the second season of the Medicus Mundi Switzerland (MMS) podcast "Health for All", Carine Weiss talks to Professor Christian Lengeler about his passion for malaria research and how the current pand

2. Vaccine Hesitancy on the Rise (Page)

   Vaccine Hesitancy on the Rise

   Relevance:
   https://www.swisstph.ch/en/impact-stories/vaccine-hesitancy-on-the-rise

   Return to list

3. Drug Discovery Work (Page)

   Drug Discovery Work

   Relevance:
   https://www.swisstph.ch/en/about/mpi/parasite-chemotherapy/drug-discovery-work

   Drug Discovery Work Tropical parasitic diseases, as malaria, African sleeping sickness, Chagas disease or Leishmaniasis represent still a large health risk for a majority of the worlds population. The

4. Fexinidazole (Page)

   Fexinidazole

   Relevance:
   https://www.swisstph.ch/en/about/med/clinical-operations/fexinidazole

   Fexinidazole to Treat Late-stage Human African Trypanosomiasis Efficacy and Safety of Fexinidazole Compared to Nifurtimox-Eflornithine Combination Therapy in Patients With Late-stage Human African Try

5. MATIAS (Page)

   MATIAS

   Relevance:
   https://www.swisstph.ch/en/about/med/medicines-implementation-research/matias

   Key Project | MATIAS Treatment of Severe Malaria with Injectable Artesunate Implementation Non-Controlled Longitudinal Observational Study to Support Artesunate Introduction in the Democratic Republic

6. Drug and Vaccine Safety (Page)

   Drug and Vaccine Safety

   Relevance:
   https://www.swisstph.ch/en/about/med/medicines-implementation-research/drug-and-vaccine-safety

   Project Focus| Drug and Vaccine Safety Developing New Knowledge on Real-Life Benefit-Risk of Medicines in Resource Limited Areas Despite the highly controlled process of clinical development, the over

7. Course List (Page)

   Course List

   Relevance:
   https://www.swisstph.ch/en/courses/course-list

8. Human Biomonitoring (Page)

   Human Biomonitoring

   Relevance:
   https://www.swisstph.ch/en/topics/non-communicable-diseases/human-biomonitoring

   Human Biomonitoring, Exposome, and Personalised Health Swiss TPH has a long-standing expertise in biomarker research. It has set up state-of-the art bio-banking infrastructure to support human biomoni

9. Promising Drug Combination Treatment Against Parasitic Worm Infections (Page)

   Promising Drug Combination Treatment Against Parasitic Worm Infections

   Relevance:
   https://www.swisstph.ch/en/news/promisingdrugcombinationtreatmentagainstparasiticworminfections

   Promising Drug Combination Treatment Against Parasitic Worm Infections 30.11.2021 In a Phase III clinical trial, researchers at Swiss TPH have successfully gathered encouraging data to demonstrate hig

10. First Malaria Vaccine Recommended for Children by the WHO (Page)

    First Malaria Vaccine Recommended for Children by the WHO

    Relevance:
    https://www.swisstph.ch/en/news/first-malaria-vaccine-recommended-for-children

    First Malaria Vaccine Recommended for Children by the WHO 07.10.2021 Yesterday, the World Health Organization (WHO) recommended the widespread use of the malaria vaccine RTS,S/AS01, debuting a tool th